SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,059.77 -331.62
( -0.43%)

Global Indices

Nasdaq

51,969.87 237.22
(0.46%)

Dow Jones

7,434.30 5.00
(0.07%)

Hang Seng

64,397.99 -2,024.61
(-3.05%)

Nikkei 225

10,738.51 99.34
(0.93%)

Forex

USD-INR

96.67 0.19
(0.20%)

EUR-INR

110.18 0.12
(0.10%)

GBP-INR

129.04 -0.01
(0.00%)

JPY-INR

0.59 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Medicamen Organics Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

92885

INE0PE401018

23.677563

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MEDIORG

30.05

EPS(TTM)

Face Value()

Div & Yield %

Back

supha pharmachem ltd

USFDA concludes inspection of Wanbury's facility at Tanuku, Andhra Pradesh

Jul 21,2026

Wanbury announced that a routine current Good Manufacturing Practices ( cGMP) inspection was conducted by the United States Food and Drug Administration (USFDA) at the company's facility at Tanuku, West Godavari District, Andhra Pradesh during the period from 13 July 2026 to 17 July 2026.

At the conclusion of the inspection, the U.S.FDA has issued a Form 483 with six observations. The Company will respond to these observations to FDA within the stipulated time.

76,059.77 -331.62 ( -0.43%)

51,969.87 237.22 (0.46%)

7,434.30 5.00 (0.07%)

64,397.99 -2,024.61 (-3.05%)

10,738.51 99.34 (0.93%)

96.67 0.19 (0.20%)

110.18 0.12 (0.10%)

129.04 -0.01 (0.00%)

0.59 0.00 (-0.04%)